SARS-CoV-2 ORF3a Protein as a Therapeutic Target against COVID-19 and Long-Term Post-Infection Effects is a research paper published in Pathogens (2024). On theSindex it has a DataRank of 0. It has been cited 15 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH R21 AI129369
Grant: I01RX003060
NIH R21 AI129369
Grant: 1I01BX004652
NIH R21 AI129369
Grant: SC170199
NIH R21 AI129369
Grant: R01HL082517
NIH R21 AI129369
Grant: R01NS102589
NIH R21 AI129369
Grant: R01NS105633
NIH R21 AI129369
Grant: G12MD007597
NINDS NIH HHS
Grant: NS105633
NIMHD NIH HHS
Grant: U54 MD007597
NIAID NIH HHS
Grant: R01 AI150459
BLRD VA
Grant: I01 BX004652
NINDS NIH HHS
Grant: NS102589
NINDS NIH HHS
Grant: NS107262
NIGMS NIH HHS
Grant: R01 GM127212
NIAID NIH HHS
Grant: SC1 AI112785
NINDS NIH HHS
Grant: R01 NS107262
NIAID NIH HHS
Grant: R21 AI129369
University of Maryland Medical Center
FWCI
4.78
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals